glp 1 mimetic example Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations | Diabetes Therapy KDIGO 2026: Glucagon-like peptide-1-based therapies

See more in our infographic:

Why a Pill is Changing the Game for Weight Loss The conversation around weight management has been dominated by injections for years, but in 2026, that narrative is fundamentally changing

Here is a simple protocol for active individuals who are often exposed to the elements

Patients may need a more careful discussion if they have a history of: Previous NAION in one eye Significant optic nerve crowding Diabetes with vascular complications Sleep apnea, especially untreated sleep apnea High blood pressure or low nighttime blood pressure Cardiovascular disease Sudden unexplained vision loss in the past This does not automatically mean a GLP-1 medication is unsafe, but it does mean the patient should have a personalized risk-benefit discussion with their medical provider

Some users report spontaneous erections or changes in libido

Results may vary from person to person